Irene lost weight fast on Ozempic after gaining during COVID, chose a facelift at 47, and Dr Karam shows how she looks now.
Recap by typeshit. Video by @dramirkaram on TikTok.
Kalkine Media ties the attention on Lilly to orforglipron's progress, arguing a pill could scale cheaper than injectables and ease supply limits.
Smaller portions could become more common on shelves, with inflation and GLP-1 appetite changes both pushing food makers toward personal packs.
Chokshi notes the sales were 0.4% of Lilly's $23 billion quarter, and that Divi's Labs hasn't announced any role in making the drug.
Oral Wegovy brought in about $850 million in H1 2026 and holds over 80% of new US oral scripts. Lilly says Foundayo volume doubled in a month.
Suspected cases of vision getting worse after taking Wegovy have now been reported domestically in South Korea, SBS says. Details on how many cases were reported weren't given.
The Google Trends jump comes with a reminder that unapproved peptides are banned in sport, plus a note on the lack of evidence behind them.
Loading…